The intervention of Astragalus polysaccharide (APS) significantly reduced the levels of hippocampal TNF-α, IL-1β, and IL-6 in rats with CUS-induced depression (Wang et al., 2018; Wang et al., 2019a; Liu et al., 2019). Here, IL1B is linked to major depressive disorder.